Takeda Wins $16.8M In Fees For Misconduct

Law360, New York (March 21, 2007, 12:00 AM EDT) -- A U.S. federal judge has ordered two generic drug makers to pay $16.8 million in legal fees to Takeda Pharmaceutical Co Ltd. for their “exceptional misconduct and bad faith” during a patent challenge last year.

Judge Denise Cote ruled Wednesday that Mylan Laboratories Inc. pick up the greater portion of the tab and pay the Japanese drug company $11.4 million.

Alphapharm has been ordered to pay the remaining $5.4 million, with the total award accruing interest from September 2006 at a rate of 5.02%.

In the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.